Our latest work showing age-related declines in placental CPT1B expression and acylcarnitine content, which may reflect reduced metabolic flexibility that contribute to increased risk of pregnancy complications in older women. @hej_yong@OliverCWatkins
https://t.co/ooBA2nBGP5
Celebrating the 100th year of the NUS O&G department by talking about placental mechanisms of maternal and fetal disease. Happy Birthday O&G! #Awesomeplacenta#Placenta#DOHaD#Obstetrics
Latest lab paper showing that myo-inositol moderates glucose-induced effects on human placental arachidonic acid metabolism. Another paper by @OliverCWatkins .😄https://t.co/XPr8zWnFHm
Placental 13 C-DHA metabolism and relationship with maternal BMI, glycemia and birthweight https://t.co/pVrM84cF6c
all about DHA🧑🔬@OliverCWatkins#DHA#placentaresearch#pubmed
DHA as an Omega 3 fatty acid is thought to be vital in many tissues. But what is it doing in the placenta and what is the placenta doing to it. Could DHA be one way by which maternal BMI leads to increased birthweight?
https://t.co/AofXK8FEmg
How do placental lipids affect fetal growth? Our new paper shows placental lipid composition is related to infant lean mass and expression of lipid-related genes. See https://t.co/dExTHlMEfq @UoS_Medicine @IFPA_Official @EarlyNutrition
Could glycemia-induced dysregulation of placental inositol synthesis and transport be permissive to accelerated fetal growth in women with diabetes? See our new paper in JCEM https://t.co/XQ3HdtfDi5 @UoS_Medicine @PlacentaSg
Myo-inositol is my current favorite and least favorite molecule.
Is this weird sugar important in diabetes, pregnancy or fetal-placental-maternal communication?
What happens when everything goes wrong. Read about it all here in my new review.
https://t.co/kfnE6fkdiR
Our recently published review on human placental transcriptomes in the Nov/Dec issue of Human Reproduction Update. #placenta#transcriptome#researchpaper
https://t.co/D3F0X0FlfT